Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen

People who receive the ChAdOx1 nCoV-19 vaccine, particularly perimenopausal women who are on birth control or postmenopausal women who take estrogen supplements, may experience thrombosis and thrombocytopenia. Estrogen and the ChAdOx1 nCoV-19 vaccine both have the potential to cause thrombus in diff...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ava Soltani Hekmat, Kazem Javanmardi
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/f4cd247227834c439d27e09af2ca52aa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f4cd247227834c439d27e09af2ca52aa
record_format	dspace
spelling	oai:doaj.org-article:f4cd247227834c439d27e09af2ca52aa2021-11-08T02:35:20ZPossible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen2314-614110.1155/2021/7702863https://doaj.org/article/f4cd247227834c439d27e09af2ca52aa2021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/7702863https://doaj.org/toc/2314-6141People who receive the ChAdOx1 nCoV-19 vaccine, particularly perimenopausal women who are on birth control or postmenopausal women who take estrogen supplements, may experience thrombosis and thrombocytopenia. Estrogen and the ChAdOx1 nCoV-19 vaccine both have the potential to cause thrombus in different ways. Some postmenopausal women who are also taking estrogens may develop thrombosis and thrombocytopenia after receiving the ChAdOx1 nCoV-19 vaccine. Therefore, women are encouraged to stop taking drugs containing estrogen before receiving this vaccine. Furthermore, consuming fish oil can help reduce the risk of developing blood clots among women who are in the luteal phase and, thus, have high estrogen levels. In addition, ChAdOx1 nCoV-19’s side effects in young women could be mitigated by administering it during the follicular phase.Ava Soltani HekmatKazem JavanmardiHindawi LimitedarticleMedicineRENBioMed Research International, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R
spellingShingle	Medicine R Ava Soltani Hekmat Kazem Javanmardi Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen
description	People who receive the ChAdOx1 nCoV-19 vaccine, particularly perimenopausal women who are on birth control or postmenopausal women who take estrogen supplements, may experience thrombosis and thrombocytopenia. Estrogen and the ChAdOx1 nCoV-19 vaccine both have the potential to cause thrombus in different ways. Some postmenopausal women who are also taking estrogens may develop thrombosis and thrombocytopenia after receiving the ChAdOx1 nCoV-19 vaccine. Therefore, women are encouraged to stop taking drugs containing estrogen before receiving this vaccine. Furthermore, consuming fish oil can help reduce the risk of developing blood clots among women who are in the luteal phase and, thus, have high estrogen levels. In addition, ChAdOx1 nCoV-19’s side effects in young women could be mitigated by administering it during the follicular phase.
format	article
author	Ava Soltani Hekmat Kazem Javanmardi
author_facet	Ava Soltani Hekmat Kazem Javanmardi
author_sort	Ava Soltani Hekmat
title	Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen
title_short	Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen
title_full	Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen
title_fullStr	Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen
title_full_unstemmed	Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen
title_sort	possible risk of thrombotic events following oxford-astrazeneca covid-19 vaccination in women receiving estrogen
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/f4cd247227834c439d27e09af2ca52aa
work_keys_str_mv	AT avasoltanihekmat possibleriskofthromboticeventsfollowingoxfordastrazenecacovid19vaccinationinwomenreceivingestrogen AT kazemjavanmardi possibleriskofthromboticeventsfollowingoxfordastrazenecacovid19vaccinationinwomenreceivingestrogen
_version_	1718443247325413376

Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen

Ejemplares similares